Sandostatin LAR Depot Interactions
There are 165 drugs known to interact with Sandostatin LAR Depot (octreotide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 6 are major, 147 are moderate, and 12 are minor.
- View all 165 medications that may interact with Sandostatin LAR Depot
- View Sandostatin LAR Depot alcohol/food interactions (1)
- View Sandostatin LAR Depot disease interactions (7)
Most frequently checked interactions
View interaction reports for Sandostatin LAR Depot (octreotide) and the medicines listed below.
- Afinitor (everolimus)
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- atorvastatin
- clonazepam
- Creon (pancrelipase)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Dilaudid (hydromorphone)
- finasteride
- furosemide
- gabapentin
- Lasix (furosemide)
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- omeprazole
- oxycodone
- pantoprazole
- potassium chloride
- Singulair (montelukast)
- spironolactone
- verapamil
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Sandostatin LAR Depot alcohol/food interactions
There is 1 alcohol/food interaction with Sandostatin LAR Depot (octreotide).
Sandostatin LAR Depot disease interactions
There are 7 disease interactions with Sandostatin LAR Depot (octreotide) which include:
- renal dysfunction
- gallbladder/biliary dysfunction
- glucose intolerance
- heart disease
- hepatic impairment
- thyroid dysfunction
- vitamin B12 deficiency
Report options
QR code containing a link to this page
More about Sandostatin LAR Depot (octreotide)
- Sandostatin LAR Depot consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
